XHKG
3613
Market cap694mUSD
Jul 10, Last price
6.57HKD
1D
1.08%
1Q
-15.01%
Jan 2017
-37.31%
IPO
-17.36%
Name
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) is an entity primarily engaged in the manufacturing, retailing, and wholesale distribution of traditional Chinese medicine and various healthcare products, catering to both bulk purchasers and individual consumers. The company further provides traditional Chinese medical consultation and treatment services. Its operational scope is divided across three key regions: Hong Kong, Mainland China, and other international markets. With a substantial retail presence, it manages 23 outlets in Hong Kong and an additional 46 stores distributed across Asia, Oceania, North America, and Europe. All its merchandise is marketed under the well-known Tong Ren Tang brand. This historic firm, established in 1669, maintains its corporate headquarters in Wan Chai, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||